Identifying factors that predict failure in treating complex bile duct stones
Predictive Factors for Cholangioscopy-Assisted Lithotripsy Failure in the Management of Complex Biliary Stones: A Retrospective Analysis
This study looks at past patients to see what factors might make it harder to successfully treat complex bile duct stones using a special procedure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Vandœuvre-lès-Nancy, Lorraine) |
| Trial ID | NCT06974695 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the management of complex bile duct stones by identifying predictive factors that may lead to failure during cholangioscopy-assisted lithotripsy using the SpyGlass system. It will analyze data from adult patients who underwent this procedure between January 1, 2018, and May 30, 2025, to determine which factors are associated with unsuccessful outcomes. The study will focus on retrospective data collection to draw insights that could improve future treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients who have undergone cholangioscopy-guided lithotripsy for bile duct stones within the specified timeframe.
Not a fit: Patients who object to the collection of their data will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols for patients with complex bile duct stones, potentially reducing the rate of procedure failures.
How similar studies have performed: While this study focuses on a specific predictive factor analysis, similar studies in the field of biliary interventions have shown promise in improving treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any adult patient who underwent cholangioscopy-guided lithotripsy for bile duct stones between January 1, 2018, and May 30, 2025 Exclusion Criteria: * Patient who objected to the collection of their data
Where this trial is running
Vandœuvre-lès-Nancy, Lorraine
- CHRU Brabois Vandoeuvre les Nancy — Vandœuvre-lès-Nancy, Lorraine, France (Recruiting)
Study contacts
- Study coordinator: Marion SCHAEFER, hospital practitioner
- Email: m.schaefer@chru-nancy.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.